{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T08:06:05Z","timestamp":1768723565201,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["91217006"],"award-info":[{"award-number":["91217006"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vanishing white matter (VWM) is a leukodystrophy caused by biallelic pathogenic variants in eukaryotic translation initiation factor 2B. To date, it remains unclear which factors contribute to VWM pathogenesis. Here, we investigated the basis of VWM pathogenesis using the <jats:italic>2b5<\/jats:italic><jats:sup><jats:italic>ho<\/jats:italic><\/jats:sup> mouse model. We first mapped the temporal proteome in the cerebellum, corpus callosum, cortex, and brainstem of <jats:italic>2b5<\/jats:italic><jats:sup><jats:italic>ho<\/jats:italic><\/jats:sup> and wild-type (WT) mice. Protein changes observed in <jats:italic>2b5<\/jats:italic><jats:sup><jats:italic>ho<\/jats:italic><\/jats:sup> mice were then cross-referenced with published proteomic datasets from VWM patient brain tissue to define alterations relevant to the human disease. By comparing <jats:italic>2b5<\/jats:italic><jats:sup><jats:italic>ho<\/jats:italic><\/jats:sup> mice with their region- and age-matched WT counterparts, we showed that the proteome in the cerebellum and cortex of <jats:italic>2b5<\/jats:italic><jats:sup><jats:italic>ho<\/jats:italic><\/jats:sup> mice was already dysregulated prior to pathology development, whereas proteome changes in the corpus callosum only occurred after pathology onset. Remarkably, protein changes in the brainstem were transient, indicating that a compensatory mechanism might occur in this region. Importantly, <jats:italic>2b5<\/jats:italic><jats:sup><jats:italic>ho<\/jats:italic><\/jats:sup> mouse brain proteome changes reflect features well-known in VWM. Comparison of the <jats:italic>2b5<\/jats:italic><jats:sup><jats:italic>ho<\/jats:italic><\/jats:sup> mouse and VWM patient brain proteomes revealed shared changes. These could represent changes that contribute to the disease or even drive its progression in patients. Taken together, we show that the <jats:italic>2b5<\/jats:italic><jats:sup><jats:italic>ho<\/jats:italic><\/jats:sup> mouse brain proteome is affected in a region- and time-dependent manner. We found that the <jats:italic>2b5<\/jats:italic><jats:sup><jats:italic>ho<\/jats:italic><\/jats:sup> mouse model partly replicates the human disease at the protein level, providing a resource to study aspects of VWM pathogenesis by highlighting alterations from early to late disease stages, and those that possibly drive disease progression.<\/jats:p>","DOI":"10.1007\/s00018-024-05258-4","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T01:02:12Z","timestamp":1716598932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proteomic dissection of vanishing white matter pathogenesis"],"prefix":"10.1007","volume":"81","author":[{"given":"Jodie H. K.","family":"Man","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parand","family":"Zarekiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Mosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"de Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna O.","family":"Debets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein","family":"Breur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"Altelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjo S.","family":"van der Knaap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7689-3042","authenticated-orcid":false,"given":"Marianna","family":"Bugiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"issue":"1","key":"5258_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1148\/radiology.213.1.r99se01121","volume":"213","author":"MS van der Knaap","year":"1999","unstructured":"van der Knaap MS, Breiter SN, Naidu S, Hart AA, Valk J (1999) Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 213(1):121\u2013133. https:\/\/doi.org\/10.1148\/radiology.213.1.r99se01121","journal-title":"Radiology"},{"issue":"10","key":"5258_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/NEN.0b013e3181f2eafa","volume":"69","author":"M Bugiani","year":"2010","unstructured":"Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS (2010) Leukoencephalopathy with vanishing white matter: a review. J Neuropathol Exp Neurol 69(10):987\u2013996. https:\/\/doi.org\/10.1097\/NEN.0b013e3181f2eafa","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"5258_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-017-1739-1","volume":"134","author":"MS van der Knaap","year":"2017","unstructured":"van der Knaap MS, Bugiani M (2017) Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms. Acta Neuropathol 134(3):351\u2013382. https:\/\/doi.org\/10.1007\/s00401-017-1739-1","journal-title":"Acta Neuropathol"},{"issue":"5","key":"5258_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1474-4422(06)70440-9","volume":"5","author":"MS van der Knaap","year":"2006","unstructured":"van der Knaap MS, Pronk JC, Scheper GC (2006) Vanishing white matter disease. Lancet Neurol 5(5):413\u2013423. https:\/\/doi.org\/10.1016\/S1474-4422(06)70440-9","journal-title":"Lancet Neurol"},{"issue":"4","key":"5258_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ng764","volume":"29","author":"PA Leegwater","year":"2001","unstructured":"Leegwater PA, Vermeulen G, Konst AA, Naidu S, Mulders J, Visser A, Kersbergen P, Mobach D, Fonds D, van Berkel CG, Lemmers RJ, Frants RR, Oudejans CB, Schutgens RB, Pronk JC, van der Knaap MS (2001) Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 29(4):383\u2013388. https:\/\/doi.org\/10.1038\/ng764","journal-title":"Nat Genet"},{"issue":"2","key":"5258_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ana.10112","volume":"51","author":"MS van der Knaap","year":"2002","unstructured":"van der Knaap MS, Leegwater PA, Konst AA, Visser A, Naidu S, Oudejans CB, Schutgens RB, Pronk JC (2002) Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 51(2):264\u2013270. https:\/\/doi.org\/10.1002\/ana.10112","journal-title":"Ann Neurol"},{"issue":"6","key":"5258_CR7","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1042\/BST20150164","volume":"43","author":"NC Wortham","year":"2015","unstructured":"Wortham NC, Proud CG (2015) eIF2B: recent structural and functional insights into a key regulator of translation. Biochem Soc Trans 43(6):1234\u20131240. https:\/\/doi.org\/10.1042\/BST20150164","journal-title":"Biochem Soc Trans"},{"key":"5258_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-3-642-56688-2_4","volume":"26","author":"CG Proud","year":"2001","unstructured":"Proud CG (2001) Regulation of eukaryotic initiation factor eIF2B. Prog Mol Subcell Biol 26:95\u2013114. https:\/\/doi.org\/10.1007\/978-3-642-56688-2_4","journal-title":"Prog Mol Subcell Biol"},{"issue":"8","key":"5258_CR9","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/acn3.50826","volume":"6","author":"TEM Abbink","year":"2019","unstructured":"Abbink TEM, Wisse LE, Jaku E, Thiecke MJ, Voltolini-Gonzalez D, Fritsen H, Bobeldijk S, Ter Braak TJ, Polder E, Postma NL, Bugiani M, Struijs EA, Verheijen M, Straat N, van der Sluis S, Thomas AAM, Molenaar D, van der Knaap MS (2019) Vanishing white matter: deregulated integrated stress response as therapy target. Ann Clin Transl Neurol 6(8):1407\u20131422. https:\/\/doi.org\/10.1002\/acn3.50826","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"5258_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ana.1227","volume":"50","author":"W Bruck","year":"2001","unstructured":"Bruck W, Herms J, Brockmann K, Schulz-Schaeffer W, Hanefeld F (2001) Myelinopathia centralis diffusa (vanishing white matter disease): evidence of apoptotic oligodendrocyte degeneration in early lesion development. Ann Neurol 50(4):532\u2013536. https:\/\/doi.org\/10.1002\/ana.1227","journal-title":"Ann Neurol"},{"issue":"3","key":"5258_CR11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/bpa.12606","volume":"28","author":"M Bugiani","year":"2018","unstructured":"Bugiani M, Vuong C, Breur M, van der Knaap MS (2018) Vanishing white matter: a leukodystrophy due to astrocytic dysfunction. Brain Pathol 28(3):408\u2013421. https:\/\/doi.org\/10.1111\/bpa.12606","journal-title":"Brain Pathol"},{"issue":"4","key":"5258_CR12","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1172\/JCI83908","volume":"126","author":"S Dooves","year":"2016","unstructured":"Dooves S, Bugiani M, Postma NL, Polder E, Land N, Horan ST, van Deijk AL, van de Kreeke A, Jacobs G, Vuong C, Klooster J, Kamermans M, Wortel J, Loos M, Wisse LE, Scheper GC, Abbink TE, Heine VM, van der Knaap MS (2016) Astrocytes are central in the pathomechanisms of vanishing white matter. J Clin Invest 126(4):1512\u20131524. https:\/\/doi.org\/10.1172\/JCI83908","journal-title":"J Clin Invest"},{"issue":"4","key":"5258_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/acn3.540","volume":"5","author":"MD Klok","year":"2018","unstructured":"Klok MD, Bugiani M, de Vries SI, Gerritsen W, Breur M, van der Sluis S, Heine VM, Kole MHP, Baron W, van der Knaap MS (2018) Axonal abnormalities in vanishing white matter. Ann Clin Transl Neurol 5(4):429\u2013444. https:\/\/doi.org\/10.1002\/acn3.540","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"5258_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/NEN.0b013e318203ae74","volume":"70","author":"M Bugiani","year":"2011","unstructured":"Bugiani M, Boor I, van Kollenburg B, Postma N, Polder E, van Berkel C, van Kesteren RE, Windrem MS, Hol EM, Scheper GC, Goldman SA, van der Knaap MS (2011) Defective glial maturation in vanishing white matter disease. J Neuropathol Exp Neurol 70(1):69\u201382. https:\/\/doi.org\/10.1097\/NEN.0b013e318203ae74","journal-title":"J Neuropathol Exp Neurol"},{"issue":"22","key":"5258_CR15","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.3390\/cells11223581","volume":"11","author":"JHK Man","year":"2022","unstructured":"Man JHK, van Gelder C, Breur M, Okkes D, Molenaar D, van der Sluis S, Abbink T, Altelaar M, van der Knaap MS, Bugiani M (2022) Cortical pathology in vanishing white matter. Cells 11(22):3581. https:\/\/doi.org\/10.3390\/cells11223581","journal-title":"Cells"},{"issue":"1","key":"5258_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40478-023-01599-6","volume":"11","author":"JHK Man","year":"2023","unstructured":"Man JHK, van Gelder C, Breur M, Molenaar D, Abbink T, Altelaar M, Bugiani M, van der Knaap MS (2023) Regional vulnerability of brain white matter in vanishing white matter. Acta Neuropathol Commun 11(1):103. https:\/\/doi.org\/10.1186\/s40478-023-01599-6","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"5258_CR17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/ana.10339","volume":"52","author":"A Fogli","year":"2002","unstructured":"Fogli A, Wong K, Eymard-Pierre E, Wenger J, Bouffard JP, Goldin E, Black DN, Boespflug-Tanguy O, Schiffmann R (2002) Cree leukoencephalopathy and CACH\/VWM disease are allelic at the EIF2B5 locus. Ann Neurol 52(4):506\u2013510. https:\/\/doi.org\/10.1002\/ana.10339","journal-title":"Ann Neurol"},{"issue":"1","key":"5258_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1074\/mcp.TIR119.001616","volume":"19","author":"J Doellinger","year":"2020","unstructured":"Doellinger J, Schneider A, Hoeller M, Lasch P (2020) Sample preparation by easy extraction and digestion (SPEED)\u2014a universal, rapid, and detergent-free protocol for proteomics based on acid extraction. Mol Cell Proteomics 19(1):209\u2013222. https:\/\/doi.org\/10.1074\/mcp.TIR119.001616","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"5258_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev V, Messner CB, Vernardis SI, Lilley KS, Ralser M (2020) DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat Methods 17(1):41\u201344. https:\/\/doi.org\/10.1038\/s41592-019-0638-x","journal-title":"Nat Methods"},{"key":"5258_CR20","unstructured":"Jankevics A, Lloyd GR, Weber RJM (2023) pmp: peak matrix processing and signal batch correction for metabolomics datasets. https:\/\/bioconductor.org\/packages\/pmp\/"},{"issue":"1","key":"5258_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","volume":"25","author":"S L\u00ea","year":"2008","unstructured":"L\u00ea S, Josse J, Husson F (2008) FactoMineR: an R package for multivariate analysis. J Stat Softw 25(1):1\u201318. https:\/\/doi.org\/10.18637\/jss.v025.i01","journal-title":"J Stat Softw"},{"issue":"7","key":"5258_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"5258_CR23","doi-asserted-by":"publisher","first-page":"W207","DOI":"10.1093\/nar\/gkad347","volume":"51","author":"L Kolberg","year":"2023","unstructured":"Kolberg L, Raudvere U, Kuzmin I, Adler P, Vilo J, Peterson H (2023) g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Res 51(W1):W207\u2013W212. https:\/\/doi.org\/10.1093\/nar\/gkad347","journal-title":"Nucleic Acids Res"},{"key":"5258_CR24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42940","volume":"8","author":"YL Wong","year":"2019","unstructured":"Wong YL, LeBon L, Basso AM, Kohlhaas KL, Nikkel AL, Robb HM, Donnelly-Roberts DL, Prakash J, Swensen AM, Rubinstein ND, Krishnan S, McAllister FE, Haste NV, O\u2019Brien JJ, Roy M, Ireland A, Frost JM, Shi L, Riedmaier S, Martin K, Dart MJ, Sidrauski C (2019) eIF2B activator prevents neurological defects caused by a chronic integrated stress response. Elife 8:e42940. https:\/\/doi.org\/10.7554\/eLife.42940","journal-title":"Elife"},{"issue":"8","key":"5258_CR25","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.3390\/cells10081858","volume":"10","author":"M Herrero","year":"2021","unstructured":"Herrero M, Daw M, Atzmon A, Elroy-Stein O (2021) The energy status of astrocytes is the achilles\u2019 heel of eIF2B-leukodystrophy. Cells 10(8):1858. https:\/\/doi.org\/10.3390\/cells10081858","journal-title":"Cells"},{"issue":"3","key":"5258_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12017-019-08551-9","volume":"21","author":"M Herrero","year":"2019","unstructured":"Herrero M, Mandelboum S, Elroy-Stein O (2019) eIF2B mutations cause mitochondrial malfunction in oligodendrocytes. Neuromolecular Med 21(3):303\u2013313. https:\/\/doi.org\/10.1007\/s12017-019-08551-9","journal-title":"Neuromolecular Med"},{"issue":"5","key":"5258_CR27","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/jnc.14024","volume":"141","author":"G Raini","year":"2017","unstructured":"Raini G, Sharet R, Herrero M, Atzmon A, Shenoy A, Geiger T, Elroy-Stein O (2017) Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease. J Neurochem 141(5):694\u2013707. https:\/\/doi.org\/10.1111\/jnc.14024","journal-title":"J Neurochem"},{"issue":"10","key":"5258_CR28","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.4103\/1673-5374.217329","volume":"12","author":"O Elroy-Stein","year":"2017","unstructured":"Elroy-Stein O (2017) Mitochondrial malfunction in vanishing white matter disease: a disease of the cytosolic translation machinery. Neural Regen Res 12(10):1610\u20131612. https:\/\/doi.org\/10.4103\/1673-5374.217329","journal-title":"Neural Regen Res"},{"issue":"6","key":"5258_CR29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1080\/1028415X.2020.1846356","volume":"25","author":"LE Wisse","year":"2022","unstructured":"Wisse LE, Visser D, Ter Braak TJ, Bakkali A, Struys EA, Morrison CD, van der Knaap MS, Abbink TEM (2022) Isocaloric low protein diet in a mouse model for vanishing white matter does not impact ISR deregulation in brain, but reveals ISR deregulation in liver. Nutr Neurosci 25(6):1219\u20131230. https:\/\/doi.org\/10.1080\/1028415X.2020.1846356","journal-title":"Nutr Neurosci"},{"issue":"11","key":"5258_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1177\/088307389901401108","volume":"14","author":"MS van der Knaap","year":"1999","unstructured":"van der Knaap MS, Wevers RA, Kure S, Gabreels FJ, Verhoeven NM, van Raaij-Selten B, Jaeken J (1999) Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter. J Child Neurol 14(11):728\u2013731. https:\/\/doi.org\/10.1177\/088307389901401108","journal-title":"J Child Neurol"},{"key":"5258_CR31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fncel.2017.00411","volume":"11","author":"LE Wisse","year":"2017","unstructured":"Wisse LE, Penning R, Zaal EA, van Berkel CGM, Ter Braak TJ, Polder E, Kenney JW, Proud CG, Berkers CR, Altelaar MAF, Speijer D, van der Knaap MS, Abbink TEM (2017) Proteomic and metabolomic analyses of vanishing white matter mouse astrocytes reveal deregulation of ER functions. Front Cell Neurosci 11:411. https:\/\/doi.org\/10.3389\/fncel.2017.00411","journal-title":"Front Cell Neurosci"},{"issue":"Pt 1","key":"5258_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/brain\/aws320","volume":"136","author":"M Bugiani","year":"2013","unstructured":"Bugiani M, Postma N, Polder E, Dieleman N, Scheffer PG, Sim FJ, van der Knaap MS, Boor I (2013) Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease. Brain 136(Pt 1):209\u2013222. https:\/\/doi.org\/10.1093\/brain\/aws320","journal-title":"Brain"},{"issue":"4","key":"5258_CR33","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00234-022-03097-3","volume":"65","author":"MD Stellingwerff","year":"2022","unstructured":"Stellingwerff MD, van de Wiel MA, van der Knaap MS (2022) Radiological correlates of episodes of acute decline in the leukodystrophy vanishing white matter. Neuroradiology 65(4):855\u2013863. https:\/\/doi.org\/10.1007\/s00234-022-03097-3","journal-title":"Neuroradiology"},{"issue":"10","key":"5258_CR34","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.bbagrm.2013.07.003","volume":"1829","author":"S Wang","year":"2013","unstructured":"Wang S, Wang Y (2013) Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. Biochim Biophys Acta 1829(10):1126\u20131135. https:\/\/doi.org\/10.1016\/j.bbagrm.2013.07.003","journal-title":"Biochim Biophys Acta"},{"issue":"6226","key":"5258_CR35","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1126\/science.aaa1934","volume":"347","author":"A Zeisel","year":"2015","unstructured":"Zeisel A, Munoz-Manchado AB, Codeluppi S, Lonnerberg P, La Manno G, Jureus A, Marques S, Munguba H, He L, Betsholtz C, Rolny C, Castelo-Branco G, Hjerling-Leffler J, Linnarsson S (2015) Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science 347(6226):1138\u20131142. https:\/\/doi.org\/10.1126\/science.aaa1934","journal-title":"Science"},{"issue":"4","key":"5258_CR36","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.celrep.2019.03.108","volume":"27","author":"AM Falcao","year":"2019","unstructured":"Falcao AM, Meijer M, Scaglione A, Rinwa P, Agirre E, Liang J, Larsen SC, Heskol A, Frawley R, Klingener M, Varas-Godoy M, Raposo A, Ernfors P, Castro DS, Nielsen ML, Casaccia P, Castelo-Branco G (2019) PAD2-mediated citrullination contributes to efficient oligodendrocyte differentiation and myelination. Cell Rep 27(4):1090-1102.e10. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.108","journal-title":"Cell Rep"},{"issue":"4\u20135","key":"5258_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1242\/dmm.000729","volume":"1","author":"AA Musse","year":"2008","unstructured":"Musse AA, Li Z, Ackerley CA, Bienzle D, Lei H, Poma R, Harauz G, Moscarello MA, Mastronardi FG (2008) Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Dis Model Mech 1(4\u20135):229\u2013240. https:\/\/doi.org\/10.1242\/dmm.000729","journal-title":"Dis Model Mech"},{"issue":"7","key":"5258_CR38","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2174\/1389450116666150202160954","volume":"16","author":"EE Witalison","year":"2015","unstructured":"Witalison EE, Thompson PR, Hofseth LJ (2015) Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation. Curr Drug Targets 16(7):700\u2013710. https:\/\/doi.org\/10.2174\/1389450116666150202160954","journal-title":"Curr Drug Targets"},{"issue":"11","key":"5258_CR39","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/cells11111773","volume":"11","author":"J Bauch","year":"2022","unstructured":"Bauch J, Faissner A (2022) The extracellular matrix proteins tenascin-C and tenascin-R retard oligodendrocyte precursor maturation and myelin regeneration in a cuprizone-induced long-term demyelination animal model. Cells 11(11):1773. https:\/\/doi.org\/10.3390\/cells11111773","journal-title":"Cells"},{"issue":"9","key":"5258_CR40","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1523\/JNEUROSCI.1517-21.2022","volume":"42","author":"CD Cristobal","year":"2022","unstructured":"Cristobal CD, Wang CY, Zuo Z, Smith JA, Lindeke-Myers A, Bellen HJ, Lee HK (2022) Daam2 regulates myelin structure and the oligodendrocyte actin cytoskeleton through Rac1 and gelsolin. J Neurosci 42(9):1679\u20131691. https:\/\/doi.org\/10.1523\/JNEUROSCI.1517-21.2022","journal-title":"J Neurosci"},{"issue":"4","key":"5258_CR41","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/cells10040883","volume":"10","author":"M Migocka-Patrzalek","year":"2021","unstructured":"Migocka-Patrzalek M, Elias M (2021) Muscle Glycogen phosphorylase and its functional partners in health and disease. Cells 10(4):883. https:\/\/doi.org\/10.3390\/cells10040883","journal-title":"Cells"},{"issue":"8","key":"5258_CR42","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrc3557","volume":"13","author":"JW Locasale","year":"2013","unstructured":"Locasale JW (2013) Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer 13(8):572\u2013583. https:\/\/doi.org\/10.1038\/nrc3557","journal-title":"Nat Rev Cancer"},{"issue":"D1","key":"5258_CR43","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, Inuganti A, Griss J, Mayer G, Eisenacher M, Perez E, Uszkoreit J, Pfeuffer J, Sachsenberg T, Yilmaz S, Tiwary S, Cox J, Audain E, Walzer M, Jarnuczak AF, Ternent T, Brazma A, Vizcaino JA (2019) The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res 47(D1):D442\u2013D450. https:\/\/doi.org\/10.1093\/nar\/gky1106","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"5258_CR44","doi-asserted-by":"publisher","first-page":"D1539","DOI":"10.1093\/nar\/gkac1040","volume":"51","author":"EW Deutsch","year":"2023","unstructured":"Deutsch EW, Bandeira N, Perez-Riverol Y, Sharma V, Carver JJ, Mendoza L, Kundu DJ, Wang S, Bandla C, Kamatchinathan S, Hewapathirana S, Pullman BS, Wertz J, Sun Z, Kawano S, Okuda S, Watanabe Y, MacLean B, MacCoss MJ, Zhu Y, Ishihama Y, Vizcaino JA (2023) The ProteomeXchange consortium at 10 years: 2023 update. Nucleic Acids Res 51(D1):D1539\u2013D1548. https:\/\/doi.org\/10.1093\/nar\/gkac1040","journal-title":"Nucleic Acids Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05258-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-024-05258-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05258-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T01:06:40Z","timestamp":1716599200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-024-05258-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5258"],"URL":"https:\/\/doi.org\/10.1007\/s00018-024-05258-4","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the Amsterdam University Medical Centers location VU University Amsterdam (2000.083, April 2000). All animal experiments were reviewed and approved by the Animal Ethics Committee of the Central Authority for Scientific Procedures on Animals of the Netherlands and the animal care and use committee of the Vrije Universiteit Amsterdam (protocol AVD1120020172804).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all subjects involved in the study by the Netherlands Brain Bank and the Amsterdam University Medical Centers.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"234"}}